Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immunotherapies
100.0
%
| 6 | 100.0 % | 7 | 100.0 % | +9.58% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 6 | 100.0 % | 7 | 100.0 % | +9.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeff Wolf
CEO | Chief Executive Officer | 60 | 08-06-09 |
Director of Finance/CFO | 56 | 19-09-24 | |
David Waldman
IRC | Investor Relations Contact | - | - |
George Peoples
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Prendergast
BRD | Director/Board Member | 70 | 16-04-25 |
Jeff Wolf
CEO | Chief Executive Officer | 60 | 08-06-09 |
Edward Smith
BRD | Director/Board Member | 48 | 08-12-31 |
John Monahan
BRD | Director/Board Member | 77 | 09-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,031,964 | 34,692,834 ( 96.28 %) | 0 | 96.28 % |
Company contact information
Scorpius Holdings, Inc.
627 Davis Drive Suite 300
27560, Morrisville
+919 240 7133
http://ww.ir.scorpiusbiologics.comSector
1st Jan change | Capi. | |
---|---|---|
+7.91% | 72.81B | |
-10.56% | 5.13B | |
+58.79% | 4.99B | |
+4.07% | 3.9B | |
-16.90% | 2.48B | |
+20.84% | 2.42B | |
-26.13% | 2.32B | |
+19.31% | 2.17B | |
-0.50% | 1.64B |